Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun:186:104020.
doi: 10.1016/j.critrevonc.2023.104020. Epub 2023 May 8.

The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer

Daniele Campa  1 Manuel Gentiluomo  2 Angelika Stein  3 Mateus Nóbrega Aoki  4 Martin Oliverius  5 Ludmila Vodičková  6 Krzysztof Jamroziak  7 George Theodoropoulos  8 Claudio Pasquali  9 William Greenhalf  10 Paolo Giorgio Arcidiacono  11 Faik Uzunoglu  12 Raffaele Pezzilli  13 Claudio Luchini  14 Marta Puzzono  15 Martin Loos  16 Matteo Giaccherini  2 Verena Katzke  17 Andrea Mambrini  18 Edita Kiudeliene  19 Kauffmann Emanuele Federico  20 Julia Johansen  21 Tamás Hussein  22 Beatrice Mohelnikova-Duchonova  23 Casper H J van Eijck  24 Hermann Brenner  25 Riccardo Farinella  2 Juan Sainz Pérez  26 Martin Lovecek  27 Markus W Büchler  16 Viktor Hlavac  28 Jakob R Izbicki  12 Thilo Hackert  16 Roger Chammas  29 Alessandro Zerbi  30 Rita Lawlor  31 Alessio Felici  2 Mara Götz  12 Gabriele Capurso  32 Laura Ginocchi  18 Maria Gazouli  33 Juozas Kupcinskas  19 Giulia Martina Cavestro  15 Pavel Vodicka  6 Stefania Moz  34 John P Neoptolemos  16 Lumir Kunovsky  35 Stig E Bojesen  21 Silvia Carrara  36 Domenica Gioffreda  37 Egidijus Morkunas  19 Olga Abian  38 Stefania Bunduc  39 Daniela Basso  40 Ugo Boggi  20 Barbara Wlodarczyk  41 Andrea Szentesi  42 Giuseppe Vanella  32 Inna Chen  21 Maarten F Bijlsma  43 Vytautas Kiudelis  19 Stefano Landi  2 Ben Schöttker  44 Chiara Corradi  2 Nathalia Giese  16 Rudolf Kaaks  17 Giulia Peduzzi  2 Péter Hegyi  45 Luca Morelli  46 Niccolò Furbetta  46 Pavel Soucek  28 Anna Latiano  37 Renata Talar-Wojnarowska  41 Sidsel C Lindgaard  21 Frederike Dijk  47 Anna Caterina Milanetto  9 Francesca Tavano  37 Klara Cervena  48 Bálint Erőss  49 Sabrina G Testoni  11 Judith H E Verhagen-Oldenampsen  50 Ewa Małecka-Wojciesko  41 Eithne Costello  10 Roberto Salvia  51 Evaristo Maiello  52 Stefano Ermini  53 Cosimo Sperti  54 Bernd Holleczek  55 Francesco Perri  37 Jurgita Skieceviciene  19 Livia Archibugi  32 Maurizio Lucchesi  18 Cosmeri Rizzato  56 Federico Canzian  57
Affiliations
Free article
Review

The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer

Daniele Campa et al. Crit Rev Oncol Hematol. 2023 Jun.
Free article

Abstract

Pancreatic cancer has an incidence that almost matches its mortality. Only a small number of risk factors and 33 susceptibility loci have been identified. so Moreover, the relative rarity of pancreatic cancer poses significant hurdles for research aimed at increasing our knowledge of the genetic mechanisms contributing to the disease. Additionally, the inability to adequately power research questions prevents small monocentric studies from being successful. Several consortia have been established to pursue a better understanding of the genetic architecture of pancreatic cancers. The Pancreatic disease research (PANDoRA) consortium is the largest in Europe. PANDoRA is spread across 12 European countries, Brazil and Japan, bringing together 29 basic and clinical research groups. In the last ten years, PANDoRA has contributed to the discovery of 25 susceptibility loci, a feat that will be instrumental in stratifying the population by risk and optimizing preventive strategies.

Keywords: Chronic pancreatitis; Consortium; Genetic epidemiology; Intraductal papillary mucinous neoplasms; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Pancreatic neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest MFB has received research funding from Celgene, Frame Therapeutics, and Lead Pharma, and has acted as a consultant to Servier.

Similar articles

Cited by

  • The 12-Year Experience of the Hungarian Pancreatic Study Group.
    Szentesi A, Hegyi P, On Behalf Of The Hungarian Pancreatic Study Group. Szentesi A, et al. J Clin Med. 2025 Feb 18;14(4):1362. doi: 10.3390/jcm14041362. J Clin Med. 2025. PMID: 40004893 Free PMC article. Review.
  • Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study.
    Daniel N, Farinella R, Chatziioannou AC, Jenab M, Mayén AL, Rizzato C, Belluomini F, Canzian F, Tavanti A, Keski-Rahkonen P, Hughes DJ, Campa D. Daniel N, et al. Sci Rep. 2024 Oct 24;14(1):25144. doi: 10.1038/s41598-024-77431-5. Sci Rep. 2024. PMID: 39448785 Free PMC article.
  • Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.
    Gálvez-Montosa F, Peduzzi G, Sanchez-Maldonado JM, Ter Horst R, Cabrera-Serrano AJ, Gentiluomo M, Macauda A, Luque N, Ünal P, García-Verdejo FJ, Li Y, López López JA, Stein A, Bueno-de-Mesquita HB, Arcidiacono PG, Zanette DL, Kahlert C, Perri F, Soucek P, Talar-Wojnarowska R, Theodoropoulos GE, Izbicki JR, Tamás H, Van Laarhoven H, Nappo G, Petrone MC, Lovecek M, Vermeulen RCH, Adamonis K, Reyes-Zurita FJ, Holleczek B, Sumskiene J, Mohelníková-Duchoňová B, Lawlor RT, Pezzilli R, Aoki MN, Pasquali C, Petrenkiene V, Basso D, Bunduc S, Comandatore A, Brenner H, Ermini S, Vanella G, Goetz MR, Archibugi L, Lucchesi M, Uzunoglu FG, Busch O, Milanetto AC, Puzzono M, Kupcinskas J, Morelli L, Sperti C, Carrara S, Capurso G, van Eijck CHJ, Oliverius M, Roth S, Tavano F, Kaaks R, Szentesi A, Vodickova L, Luchini C, Schöttker B, Landi S, Dohan O, Tacelli M, Greenhalf W, Gazouli M, Neoptolemos JP, Cavestro GM, Boggi U, Latiano A, Hegyi P, Ginocchi L, Netea MG, Sánchez-Rovira P, Canzian F, Campa D, Sainz J. Gálvez-Montosa F, et al. Int J Cancer. 2025 Jan 15;156(2):339-352. doi: 10.1002/ijc.35196. Epub 2024 Sep 25. Int J Cancer. 2025. PMID: 39319538 Free PMC article.
  • The future of collaborative precision oncology approaches in sub-Saharan Africa: learnings from around the globe.
    Gueye A, Maroun B, Zimur A, Berkovits T, Tan SM. Gueye A, et al. Front Oncol. 2024 Jun 21;14:1426558. doi: 10.3389/fonc.2024.1426558. eCollection 2024. Front Oncol. 2024. PMID: 38974239 Free PMC article.
  • Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.
    Piccardi M, Gentiluomo M, Bertoncini S, Pezzilli R, Erőss B, Bunduc S, Uzunoglu FG, Talar-Wojnarowska R, Vanagas T, Sperti C, Oliverius M, Aoki MN, Ermini S, Hussein T, Boggi U, Jamroziak K, Maiello E, Morelli L, Vodickova L, Di Franco G, Landi S, Szentesi A, Lovecek M, Puzzono M, Tavano F, van Laarhoven HWM, Zerbi A, Mohelnikova-Duchonova B, Stocker H, Costello E, Capurso G, Ginocchi L, Lawlor RT, Vanella G, Bazzocchi F, Izbicki JR, Latiano A, Bueno-de-Mesquita B, Ponz de Leon Pisani R, Schöttker B, Soucek P, Hegyi P, Gazouli M, Hackert T, Kupcinskas J, Poskiene L, Tacelli M, Roth S, Carrara S, Perri F, Hlavac V, Theodoropoulos GE, Busch OR, Mambrini A, van Eijck CHJ, Arcidiacono P, Scarpa A, Pasquali C, Basso D, Lucchesi M, Milanetto AC, Neoptolemos JP, Cavestro GM, Janciauskas D, Chen X, Chammas R, Goetz M, Brenner H, Archibugi L, Dannemann M, Canzian F, Tofanelli S, Campa D. Piccardi M, et al. Biol Res. 2023 Aug 13;56(1):46. doi: 10.1186/s40659-023-00457-y. Biol Res. 2023. PMID: 37574541 Free PMC article.

LinkOut - more resources